Literature DB >> 11172352

Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease.

L M Forman, M R Lucey.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11172352     DOI： 10.1053/jhep.2001.22481

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  41 in total

1.  De novo combination therapy with lamivudine and adefovir dipivoxil in chronic hepatitis B patients.

Authors:  Xiao-Hong Fan; Jian-Zhang Geng; Li-Fen Wang; Ying-Ying Zheng; Hai-Ying Lu; Jing Li; Xiao-Yuan Xu
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Transjugular intrahepatic porto-systemic shunt in the elderly: Palliation for complications of portal hypertension.

Authors:  Mubin I Syed; Hetal Karsan; Hector Ferral; Azim Shaikh; Uzma Waheed; Talal Akhter; Alan Gabbard; Kamal Morar; Robert Tyrrell
Journal:  World J Hepatol       Date:  2012-02-27

3.  MELD as a metric for survival benefit of liver transplantation.

Authors:  Xun Luo; Joseph Leanza; Allan B Massie; Jacqueline M Garonzik-Wang; Christine E Haugen; Sommer E Gentry; Shane E Ottmann; Dorry L Segev
Journal:  Am J Transplant       Date:  2018-02-19       Impact factor: 8.086

4.  MELD score does not discriminate against patients with hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Kia Saeian
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

5.  Predicting utility of a model for end stage liver disease in alcoholic liver disease.

Authors:  Aspasia S Soultati; Spyridon P Dourakis; Alexandra Alexopoulou; Melanie Deutsch; Larissa Vasilieva; Athanasios J Archimandritis
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

6.  Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?

Authors:  Kumar Sandrasegaran; Enming Cui; Reem Elkady; Pauley Gasparis; Gitasree Borthakur; Mark Tann; Suthat Liangpunsakul
Journal:  Eur Radiol       Date:  2018-04-12       Impact factor: 5.315

7.  MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.

Authors:  F Botta; E Giannini; P Romagnoli; A Fasoli; F Malfatti; B Chiarbonello; E Testa; D Risso; G Colla; R Testa
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

8.  Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis.

Authors:  Patrick G Northup; Ryan C Wanamaker; Vanessa D Lee; Reid B Adams; Carl L Berg
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

9.  Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.

Authors:  Yogesh K Chawla; Ramesh Chillal Kashinath; Ajay Duseja; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

10.  Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.

Authors:  Takuya Genda; Takafumi Ichida; Shotaro Sakisaka; Michio Sata; Eiji Tanaka; Ayano Inui; Hiroto Egawa; Kouji Umeshita; Hiroyuki Furukawa; Seiji Kawasaki; Yukihiro Inomata
Journal:  J Gastroenterol       Date:  2013-03-12       Impact factor: 7.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.